Oruvail 2.5% w/w gel and Orugesic 2.5% w/w gel (ketoprofen) - Important Safety Information from Sanofi-Aventis as approved by the Irish Medicines Board
14 February 2011
Important Safety Information from Sanofi-Aventis on risk minimisation measures for ketoprofen-containing topical formulations
Important Safety Information - Oruvail 2.5% w/w gel and Orugesic 2.5% w/w gel (ketoprofen)